Regeneron's experimental gene therapy improves hearing in one patient
(Reuters) - Regeneron Pharmaceuticals said on Wednesday its investigational gene therapy improved hearing to normal levels in a child within 24 weeks in an early to mid-stage study.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Shounak Dasgupta)